From our latest issue...
- Artificial intelligence in drug discovery: how long before we see the real impact?
- Proteogenomics research – on the frontier of precision medicine
- Expert view: Conquering late stage failures with advanced hit-to-lead techniques
- Identification of hits and leads for human African trypanosomiasis
- Informatics infrastructure for public-private collaborations in neglected disease research